#genes2me

[pathologylab]

Today, on #WorldDownSyndromeDay, we celebrate the power of diversity and the beauty of inclusion. Let’s continue to raise awareness, break barriers, and create a world where everyone’s potential is recognized and valued.

#InclusionForAll #DifferentNotLess #g2m #genes2me #syndromeday #day2025 #beauty #healthcare #downsyndromeday #awareness #world #celebrate #nipt #downsyndromeawareness

[pathologylab]

HPV awareness and education is the key for preventing various HPV-related cancers. One of them is cervical cancer, a disease that kills thousands of women every year. Being a virus-borne infection, HPV infections are communicable that can travel among people through skin-to-skin contact (sexual intercourse). There are over 100 strains of HPV, more than 40 of which are passed through sexual contact and can affect your genitals, mouth, or throat. Genes2Me HPV-Q Comprehensive Real-Time PCR kit screens for the presence/absence of HPV in genotypes. Take the test today to determine your risk of HPV.

For more details, Call us at 18001214030 or drop us an email at [email protected] for an Appointment

To know more visit https://t2m.io/HPVKits

[pathologylab]

Lipodystrophy is a term that refers to a group of disorders in which our body fails to produce fat (total fat loss) or abnormally accumulates fat. It can be both congenital or acquired & partial or generalised. This condition is usually manifested with other metabolic abnormalities normally related with Diabetes, PCOS, hypertriglyceridemia. Lipodystrophy are of many types but when present in generalised congenital form, it is presented very severely and mostly inherited in autosomal recessive manner. If presented in partial form, it can be inherited in an autosomal dominant manner too. Exome Sequencing can help in identification of mutated genes responsible for this heterogeneous condition. Know more about Exome Sequencing with Genes2Me #WorldLipodystrophyDay #liposydtrophy #exomesequencing #adiposetissue #diagnostic #familial #healthcare #health #skincare

Connect Today - #GENES2ME

18001214030

[pathologylab]

📢 Join us at #ESHG_2026 for an engaging corporate session exploring how Next-Generation #Sequencing is driving meaningful clinical impact across diverse #healthcare applications.

Beyond the #Genome: Clinical Insights & Real-World Impact Across Liquid Biopsy, #NIPT & #Pharmacogenomics

📅 15 June 2026

🕥 10:30 – 11:30 AM CEST

📍 Room A7, Svenska Mässan, Gothenburg, Sweden

🔗 Register here: https://forms.office.com/r/RDKh8pdCmJ

Discover the latest advancements, #clinical insights, and real-world #applications shaping the future of precision medicine through #genomics.

Hear from leading experts as they discuss:

🔹 Liquid Biopsy in oncology and disease monitoring

🔹 NIPT and the evolving landscape of prenatal screening

🔹 Pharmacogenomics and personalized therapeutic decision-making

Whether you're a clinician, #researcher, geneticist, or healthcare professional, this session offers valuable perspectives on the expanding role of #NGS in modern #medicine.

We look forward to seeing you there!

#g2m #genes2me #conference #webinar #event #ESHG #eshgCorporateSession #nextgenerationsequencing

[pathologylab]

Empower early detection with the #Genes2Me BRCA NGS Assay — enabling comprehensive hereditary risk assessment for Breast & Ovarian #Cancer. With complete #BRCA1&2 CDS coverage, CNV detection, and advanced interpretation support via #CliSeq Interpreter, the assay helps drive timely, informed clinical decisions for better women’s #health outcomes.

Visit our website for more information: https://genes2me.com/ngs/oncology-breast-cancer-testing-panel

#ovariancancer #breastcancer #g2m #brca #clinical #ngs #assay #ngsassay #healthcare #womens

[pathologylab]

🧬 Every patient responds differently to treatment - and #pharmacogenomics is helping us understand why.

On #GlobalPharmacogenomicsDay, we celebrate the power of genetics in enabling safer, smarter, and more personalized #healthcare decisions. From reducing adverse #drug reactions to improving therapeutic outcomes, #PGx is shaping the future of precision #medicine.

At #Genes2Me, we are proud to contribute to this transformation through the #Med4Me PGx Assay - empowering clinicians with actionable genetic insights for optimized therapy selection.

From #Genetic Insight to Therapeutic Precision.

#g2m #day #global #assay #celebration

[pathologylab]

39M people live with HIV-AIDS globally. High #mutation rate in HIV remains a key barrier to vaccine development. Early testing and #awareness are critical in the fight against #HIV. Every test brings us closer to a world free of #AIDS - because knowledge is the first step to change.

#awarenessmonth #month #g2m #genes2me #hiv #healthcare #solution #testing #days #testing #world #worldaids #vaccine

[pathologylab]

#Genes2Me PanCan CGP #NGS Assay is a comprehensive, next generation sequencing-based #solution designed for multi-cancer genomic profiling. It enables simultaneous detection of clinically relevant mutations, #TMB, MSI, fusions across wide range of solid tumors, supporting precision #oncology and personalized treatment using #G2M Cliseq Interpreter solution.

#ngsassay #assay #testingsolution #testing #personalized #msi #mutations #cgp #pancan #healthcare